Wegovy Pills Triumph Over Eli Lilly’s Foundry Early on Business May 4, 2026 The article discusses the recent launch of the Wegovy oral tablets by Novo Nordisk, which has significantly impacted telemedicine provider…
Eli Lilly’s Letartortide Achieves Success in First Late-Stage Weight Loss Trial Business December 11, 2025 Eli Lilly announced promising results for its next-generation obesity drug, letaltortide, revealing it achieved the highest weight loss ever recorded…
Eli Lilly’s Stock Takes a Dive: Understanding the Decline Business August 7, 2025 Eli Lilly’s shares plummeted 14% after the company reported results for its obesity drug, Orforglipron, which fell short of expectations.…
